EUVIMEDEUVIMED entdecken
Crossref

Serum and urine metabolomics analyses reveal metabolic pathways and biomarkers in relation to nasopharyngeal carcinoma

Zhaohui Liao, Li Zhao, Fangyan Zhong, Yumeng Zhou, Tianzhu Lu, Lijuan Liu, Xiaochang Gong, Jingao Li, Jun Rao iD

Rapid Communications in Mass Spectrometry · 2023

DOI: 10.1002/rcm.9469 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, 2023. Verfasst von Zhaohui Liao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Clinical Research Center for Cancer, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, People's …. Hauptthemen laut MEDLINE: Metabolomics, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Jiangxi Provincial Department of Science, Excellent Young Scientists Fund of Jiangxi Cancer Hospital, NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Nasopharyngeal carcinoma (NPC) is a malignant tumor that is endemic in Southeast Asia, North Africa, and southern China. There is an urgent need for effective early diagnosis and treatment of this disease since NPC is currently often detected at advanced stages.

Methods

To reveal the underlying metabolic mechanisms and discover potential diagnostic biomarkers of NPC, we employed ultrahigh‐performance liquid chromatography coupled with quadrupole time‐of‐flight mass spectrometry (UHPLC‐Q‐TOF‐MS) and UHPLC‐Q‐Exactive Orbitrap MS, respectively, to analyze 54 serum samples and 54 urine samples from 27 patients with NPC and 27 healthy control individuals.

Results

A total of 1230 metabolites were determined in serum samples, and 181 of the 1230 metabolites were significantly changed in NPC patients. The 181 metabolites were enriched in 16 pathways, including biosynthesis of unsaturated fatty acids, cholesterol metabolism, and ferroptosis. A total of 2509 metabolites were detected in the urine samples. Among them, 179 metabolites were significantly altered in NPC patients, and these metabolites were enriched in eight pathways, including the tricarboxylic acid (TCA) cycle and caffeine metabolism. Seven metabolites, including creatinine and paraxanthine, were found to be significantly changed in both NPC serum and urine samples. Based on them, further biomarker analysis revealed that the panel of three serum metabolites, octanoylcarnitine, creatinine, and decanoyl‐l‐carnitine, displayed a perfect diagnostic performance (area under the curve [AUC] = 0.973) to distinguish NPC patients from controls, while the other three‐metabolite biomarker panel, consisting of stachydrine, decanoyl‐l‐carnitine, and paraxanthine, had an AUC = 0.809 to distinguish NPC and control in urine samples.

Conclusion

This work highlights the key metabolites and metabolic pathways disturbed in NPC and presents potential biomarkers for effective diagnosis of this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetabolomicsNasopharyngeal NeoplasmsHumansNasopharyngeal CarcinomaCreatinineChromatography, High Pressure LiquidBiomarkersMetabolic Networks and PathwaysCarnitine

Substanzen

CreatinineBiomarkersCarnitine

Autor:innen und Institutionen

  • Jiangxi Clinical Research Center for Cancer, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, People's Republic of China.
  • School of Nursing, Nanchang University, Nanchang, Jiangxi, China.
  • National Health Commission Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma (Jiangxi Cancer Hospital), Nanchang, Jiangxi, China.
  • Jiangxi Key Laboratory of Translational Cancer Research, Jiangxi Cancer Hospital, Nanchang, Jiangxi, China.

ORCID-Profile: Jun Rao

Förderung

  • Jiangxi Provincial Department of Science
  • Excellent Young Scientists Fund of Jiangxi Cancer Hospital
  • NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma
  • Science and Technology Plan Project of Jiangxi Provincial Health Commission
  • Jiangxi Provincial Department of Science and Technology

Zitieren

APA

Liao, Z., Zhao, L., Zhong, F., Zhou, Y., Lu, T., Liu, L., Gong, X., Li, J., & Rao, J. (2023). Serum and urine metabolomics analyses reveal metabolic pathways and biomarkers in relation to nasopharyngeal carcinoma. Rapid Communications in Mass Spectrometry. https://doi.org/10.1002/rcm.9469

Vancouver

Liao Z, Zhao L, Zhong F, Zhou Y, Lu T, Liu L, et al. Serum and urine metabolomics analyses reveal metabolic pathways and biomarkers in relation to nasopharyngeal carcinoma. Rapid Communications in Mass Spectrometry. 2023. doi:10.1002/rcm.9469

BibTeX
@article{Liao2023,
  author = {Liao, Zhaohui and Zhao, Li and Zhong, Fangyan and Zhou, Yumeng and Lu, Tianzhu and Liu, Lijuan and Gong, Xiaochang and Li, Jingao and Rao, Jun},
  title = {Serum and urine metabolomics analyses reveal metabolic pathways and biomarkers in relation to nasopharyngeal carcinoma},
  journal = {Rapid Communications in Mass Spectrometry},
  year = {2023},
  doi = {10.1002/rcm.9469}
}
Kostenlos starten →